Leveljump Healthcare Corp
Leveljump Healthcare Corp., together with its subsidiaries, provides radiology services. The company offers direct patient images and teleradiology services; in-patient diagnostic imaging facilities, including x-rays, ultrasounds, and mammography; and other medical services. It serves hospitals and clinics. Leveljump Healthcare Corp. is headquartered in Toronto, Canada.
Leveljump Healthcare Corp (JMPHF) - Net Assets
Latest net assets as of September 2025: $6.35 Million USD
Based on the latest financial reports, Leveljump Healthcare Corp (JMPHF) has net assets worth $6.35 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($21.84 Million) and total liabilities ($15.49 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.35 Million |
| % of Total Assets | 29.07% |
| Annual Growth Rate | 126.98% |
| 5-Year Change | 1844.44% |
| 10-Year Change | N/A |
| Growth Volatility | 184.7 |
Leveljump Healthcare Corp - Net Assets Trend (2019–2024)
This chart illustrates how Leveljump Healthcare Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Leveljump Healthcare Corp (2019–2024)
The table below shows the annual net assets of Leveljump Healthcare Corp from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $6.36 Million | +28.74% |
| 2023-12-31 | $4.94 Million | -21.19% |
| 2022-12-31 | $6.27 Million | +217.08% |
| 2021-12-31 | $1.98 Million | +504.39% |
| 2020-12-31 | $327.10K | +210.34% |
| 2019-12-31 | $105.40K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Leveljump Healthcare Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1467760800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $21.89 Million | 344.13% |
| Total Equity | $6.36 Million | 100.00% |
Leveljump Healthcare Corp Competitors by Market Cap
The table below lists competitors of Leveljump Healthcare Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Graphene & Solar Technologies Limited
PINK:GSTX
|
$1.17 Million |
|
Akash Infra-Projects Limited
NSE:AKASH
|
$1.17 Million |
|
Lamar Advertising Company (REIT)
DU:6LA
|
$1.17 Million |
|
District Mines Ltd
V:DIG-H
|
$1.17 Million |
|
Hutchison Telecommunications (Australia) Ltd
AU:HTA
|
$1.16 Million |
|
Escalon Medical Corp
OTCQB:ESMC
|
$1.16 Million |
|
Commander Resources Ltd
PINK:CMDRF
|
$1.16 Million |
|
JADE ROAD INVESTMENTS LTD
F:1CP0
|
$1.16 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Leveljump Healthcare Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,940,203 to 6,360,256, a change of 1,420,053 (28.7%).
- Net income of 1,160,544 contributed positively to equity growth.
- Other factors increased equity by 259,509.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $1.16 Million | +18.25% |
| Other Changes | $259.51K | +4.08% |
| Total Change | $- | 28.74% |
Book Value vs Market Value Analysis
This analysis compares Leveljump Healthcare Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.28x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 7.01x to 0.28x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $0.00 | $0.02 | x |
| 2020-12-31 | $0.01 | $0.02 | x |
| 2021-12-31 | $0.03 | $0.02 | x |
| 2022-12-31 | $0.07 | $0.02 | x |
| 2023-12-31 | $0.05 | $0.02 | x |
| 2024-12-31 | $0.07 | $0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Leveljump Healthcare Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 18.25%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.55%
- • Asset Turnover: 0.84x
- • Equity Multiplier: 3.34x
- Recent ROE (18.25%) is above the historical average (-35.12%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -39.36% | -2.36% | 2.77x | 6.01x | $-161.46K |
| 2021 | -112.75% | -33.17% | 1.64x | 2.07x | $-2.43 Million |
| 2022 | 2.95% | 2.00% | 0.70x | 2.12x | $-441.85K |
| 2023 | -44.70% | -17.55% | 0.64x | 3.96x | $-2.70 Million |
| 2024 | 18.25% | 6.55% | 0.84x | 3.34x | $524.52K |
Industry Comparison
This section compares Leveljump Healthcare Corp's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $914,015,556
- Average return on equity (ROE) among peers: -22.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Leveljump Healthcare Corp (JMPHF) | $6.35 Million | -39.36% | 2.44x | $1.16 Million |
| Agilent Technologies Inc (A) | $4.08 Billion | 3.46% | 0.65x | $31.80 Billion |
| Amer Bio Medica (ABMC) | $3.38 Million | -26.64% | 1.08x | $3.55K |
| ADCNF (ADCNF) | $1.77 Billion | 2.65% | 1.64x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.68 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $8.18 Million | -45.26% | 0.31x | $35.63K |
| Avricore Health Inc (AVCRF) | $2.20 Million | -79.50% | 0.04x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $-11.46 Million | 0.00% | 0.00x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $50.38 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |